These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14667209)

  • 1. Synthesis, in vitro affinity, and efficacy of a bis 8-ethynyl-4H-imidazo[1,5a]- [1,4]benzodiazepine analogue, the first bivalent alpha5 subtype selective BzR/GABA(A) antagonist.
    Li X; Cao H; Zhang C; Furtmueller R; Fuchs K; Huck S; Sieghart W; Deschamps J; Cook JM
    J Med Chem; 2003 Dec; 46(26):5567-70. PubMed ID: 14667209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive models for GABAA/benzodiazepine receptor subtypes: studies of quantitative structure-activity relationships for imidazobenzodiazepines at five recombinant GABAA/benzodiazepine receptor subtypes [alphaxbeta3gamma2 (x = 1-3, 5, and 6)] via comparative molecular field analysis.
    Huang Q; Liu R; Zhang P; He X; McKernan R; Gan T; Bennett DW; Cook JM
    J Med Chem; 1998 Oct; 41(21):4130-42. PubMed ID: 9767648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel, selective GABA(A) alpha5 receptor inverse agonist which enhances cognition.
    Chambers MS; Atack JR; Broughton HB; Collinson N; Cook S; Dawson GR; Hobbs SC; Marshall G; Maubach KA; Pillai GV; Reeve AJ; MacLeod AM
    J Med Chem; 2003 May; 46(11):2227-40. PubMed ID: 12747794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of 3-heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and analogues as subtype-selective inverse agonists for the GABA(A)alpha5 benzodiazepine binding site.
    Street LJ; Sternfeld F; Jelley RA; Reeve AJ; Carling RW; Moore KW; McKernan RM; Sohal B; Cook S; Pike A; Dawson GR; Bromidge FA; Wafford KA; Seabrook GR; Thompson SA; Marshall G; Pillai GV; Castro JL; Atack JR; MacLeod AM
    J Med Chem; 2004 Jul; 47(14):3642-57. PubMed ID: 15214791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore/receptor models for GABA(A)/BzR alpha2beta3gamma2, alpha3beta3gamma2 and alpha4beta3gamma2 recombinant subtypes. Included volume analysis and comparison to alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2 subtypes.
    He X; Huang Q; Ma C; Yu S; McKernan R; Cook JM
    Drug Des Discov; 2000; 17(2):131-71. PubMed ID: 11045902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proconvulsant effects of the GABAA alpha5 subtype-selective compound RY-080 may not be alpha5-mediated.
    Atack JR; Bayley PJ; Fletcher SR; McKernan RM; Wafford KA; Dawson GR
    Eur J Pharmacol; 2006 Oct; 548(1-3):77-82. PubMed ID: 16962577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of imidazo[1,2-b][1,2,4]triazines as GABA(A) alpha2/3 subtype selective agonists for the treatment of anxiety.
    Russell MG; Carling RW; Street LJ; Hallett DJ; Goodacre S; Mezzogori E; Reader M; Cook SM; Bromidge FA; Newman R; Smith AJ; Wafford KA; Marshall GR; Reynolds DS; Dias R; Ferris P; Stanley J; Lincoln R; Tye SJ; Sheppard WF; Sohal B; Pike A; Dominguez M; Atack JR; Castro JL
    J Med Chem; 2006 Feb; 49(4):1235-8. PubMed ID: 16480260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High affinity central benzodiazepine receptor ligands: synthesis and biological evaluation of a series of phenyltriazolobenzotriazindione derivatives.
    Primofiore G; Da Settimo F; Taliani S; Salerno S; Novellino E; Greco G; Cosimelli B; Besnard F; Costa B; Montali M; Martini C
    J Med Chem; 2005 Apr; 48(8):2936-43. PubMed ID: 15828832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.
    Huang Q; He X; Ma C; Liu R; Yu S; Dayer CA; Wenger GR; McKernan R; Cook JM
    J Med Chem; 2000 Jan; 43(1):71-95. PubMed ID: 10633039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo labelling of alpha5 subunit-containing GABA(A) receptors using the selective radioligand [(3)H]L-655,708.
    Atack JR; Alder L; Cook SM; Smith AJ; McKernan RM
    Neuropharmacology; 2005 Aug; 49(2):220-9. PubMed ID: 15996568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1.
    Carling RW; Moore KW; Street LJ; Wild D; Isted C; Leeson PD; Thomas S; O'Connor D; McKernan RM; Quirk K; Cook SM; Atack JR; Wafford KA; Thompson SA; Dawson GR; Ferris P; Castro JL
    J Med Chem; 2004 Mar; 47(7):1807-22. PubMed ID: 15027873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent 4-arylalkyl-substituted 3-isothiazolol GABA(A) competitive/noncompetitive antagonists: synthesis and pharmacology.
    Krehan D; Storustovu SI; Liljefors T; Ebert B; Nielsen B; Krogsgaard-Larsen P; Frølund B
    J Med Chem; 2006 Feb; 49(4):1388-96. PubMed ID: 16480274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Phenyl-imidazo[1,2-a]pyridine compounds containing hydrophilic groups as potent and selective ligands for peripheral benzodiazepine receptors: synthesis, binding affinity and electrophysiological studies.
    Denora N; Laquintana V; Pisu MG; Dore R; Murru L; Latrofa A; Trapani G; Sanna E
    J Med Chem; 2008 Nov; 51(21):6876-88. PubMed ID: 18834105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Substituted imidazole-4-acetic acid analogues: synthesis, modeling, and pharmacological characterization of a series of novel gamma-aminobutyric acid(C) receptor agonists.
    Madsen C; Jensen AA; Liljefors T; Kristiansen U; Nielsen B; Hansen CP; Larsen M; Ebert B; Bang-Andersen B; Krogsgaard-Larsen P; Frølund B
    J Med Chem; 2007 Aug; 50(17):4147-61. PubMed ID: 17655213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6,3'-Dinitroflavone is a low efficacy modulator of GABA(A) receptors.
    Furtmueller R; Furtmueller B; Ramerstorfer J; Paladini AC; Wasowski C; Marder M; Huck S; Sieghart W
    Eur J Pharmacol; 2008 Sep; 591(1-3):142-6. PubMed ID: 18639544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel gamma-aminobutyric acid rho1 receptor antagonists; synthesis, pharmacological activity and structure-activity relationships.
    Kumar RJ; Chebib M; Hibbs DE; Kim HL; Johnston GA; Salam NK; Hanrahan JR
    J Med Chem; 2008 Jul; 51(13):3825-40. PubMed ID: 18528996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of functionally selective 7,8,9,10-tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazines as GABA A receptor agonists at the alpha3 subunit.
    Russell MG; Carling RW; Atack JR; Bromidge FA; Cook SM; Hunt P; Isted C; Lucas M; McKernan RM; Mitchinson A; Moore KW; Narquizian R; Macaulay AJ; Thomas D; Thompson SA; Wafford KA; Castro JL
    J Med Chem; 2005 Mar; 48(5):1367-83. PubMed ID: 15743180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, structure-activity relationships at the GABA(A) receptor in rat brain, and differential electrophysiological profile at the recombinant human GABA(A) receptor of a series of substituted 1,2-diphenylimidazoles.
    Asproni B; Talani G; Busonero F; Pau A; Sanna S; Cerri R; Mascia MP; Sanna E; Biggio G
    J Med Chem; 2005 Apr; 48(7):2638-45. PubMed ID: 15801854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the stable conformation of GABA(A)-benzodiazepine receptor bivalent ligands by low temperature NMR and X-ray analysis.
    Han D; Försterling FH; Li X; Deschamps JR; Cao H; Cook JM
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1465-9. PubMed ID: 15006383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine: a functionally selective gamma-aminobutyric acid(A) (GABA(A)) alpha2/alpha3-subtype selective agonist that exhibits potent anxiolytic activity but is not sedating in animal models.
    Carling RW; Madin A; Guiblin A; Russell MG; Moore KW; Mitchinson A; Sohal B; Pike A; Cook SM; Ragan IC; McKernan RM; Quirk K; Ferris P; Marshall G; Thompson SA; Wafford KA; Dawson GR; Atack JR; Harrison T; Castro JL; Street LJ
    J Med Chem; 2005 Nov; 48(23):7089-92. PubMed ID: 16279764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.